US Patent 9139649 Humanized anti-CD22 antibody
Patent 9139649 was granted and assigned to IMMUNOMEDICS, INC. on September, 2015 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 22, 2015
Date of Patent
September 22, 2015
Patent Applicant
Patent Application Number
14603011
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9139649 Humanized anti-CD22 antibody
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
